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In the original publication of the article, Figures 2, 3, 5, 11 and 13 were published incorrectly. The correct version of Fig. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, [11](#Fig11){ref-type="fig"} and [13](#Fig13){ref-type="fig"} are given below,Fig. 2Representative H&E staining in area postrema along with ileum of rats and minks (100 × magnification). The figures show the H&E staining in area postrema along with ileum of rats and minks (rats: *n* = 5, minks: *n* = 6). Bar indicates 100 µm. *C* normal control group, *CG* simple gingerol control group, *V* cisplatin control group, *M* cisplatin + metoclopramide group, *GL* cisplatin + low-dose gingerol group, *GM* cisplatin + middle-dose gingerol group, *GH* cisplatin + high-dose gingerol group. The red arrow shows the nerve cell, black arrow shows the epithelial cell, and blue arrow shows the inflammatory cellFig. 35-HT immunostaining expression in area postrema in addition to ileum of rats and minks. **a** Immunohistochemistry manifestation of 5-HT in area postrema in addition to ileum of rats and minks (rats: *n* = 5, minks: *n* = 6). Bar indicates 100 µm. **b** Mean optical density values of 5-HT. The images were quantified by Image-Pro Plus. *C* normal control group, *CG* simple gingerol control group, *V* cisplatin control group, *M* cisplatin + metoclopramide group, *GL* cisplatin + low-dose gingerol group, *GM* cisplatin + middle-dose gingerol group, *GH* cisplatin + high-dose gingerol group. ^\*^*P* \< 0.05 vs. Group C, ^‡^*P* \< 0.05 vs. Group CG, ^†^*P* \< 0.05 vs. Group V, ^§^*P* \< 0.05 vs. Group M, ^\|\|^*P* \< 0.05 vs. Group GL, ^¶^*P* \< 0.05 vs. Group GM. *5-HT* 5-tyrosine hydroxylaseFig. 5TPH immunostaining manifestation in area postrema as well as ileum of rats and minks. **a** Immunohistochemistry manifestation of TPH~2~ in area postrema of rats plus minks, and TPH~1~ in ileum of rats and minks (rats: *n* = 5, minks: *n* = 6). Bar indicates 100 µm. **b** Mean optical density values of TPH~2~ and TPH~1~. The images were quantified by Image-Pro Plus. *C* normal control group, *CG* simple gingerol control group, *V* cisplatin control group, *M* cisplatin + metoclopramide group, *GL* cisplatin + low-dose gingerol group, *GM* cisplatin + middle-dose gingerol group, *GH* cisplatin + high-dose gingerol group. ^\*^*P* \< 0.05 vs. Group C, ^‡^*P* \< 0.05 vs. Group CG, ^†^*P* \< 0.05 vs. Group V, ^§^*P* \< 0.05 vs. Group M, ^\|\|^*P* \< 0.05 vs. Group GL, ^¶^*P* \< 0.05 vs. Group GM. *TPH*~*1*~ tryptophan hydroxylase 1, *TPH*~*2*~ tryptophan hydroxylase 2Fig. 11DA immunostaining expression in area postrema in addition to ileum of rats and minks. **a** Immunohistochemistry manifestation of DA in area postrema plus ileum of rats and minks (rats: *n* = 5, minks: *n* = 6). Bar indicates 100 µm. **b** Mean optical density values of DA. The images were quantified by Image-Pro Plus. *C* normal control group, *CG* simple gingerol control group, *V* cisplatin control group, *M* cisplatin + metoclopramide group, *GL* cisplatin + low-dose gingerol group, *GM* cisplatin + middle-dose gingerol group, *GH* cisplatin + high-dose gingerol group. ^\*^*P* \< 0.05 vs. Group C, ^‡^*P* \< 0.05 vs. Group CG, ^†^*P* \< 0.05 vs. Group V, ^§^*P* \< 0.05 vs. Group M, ^\|\|^*P* \< 0.05 vs. Group GL, ^¶^*P* \< 0.05 vs. Group GM. *DA* dopamineFig. 13TH immunostaining manifestation in area postrema in addition to ileum of rats and minks. **a** Immunohistochemistry manifestation of TH in area postrema plus ileum of rats and minks (rats: *n* = 5, minks: *n* = 6). Bar indicates 100 µm. **b** Mean optical density values of TH. The images were quantified by Image-Pro Plus. *C* normal control group, *CG* simple gingerol control group, *V* cisplatin control group, *M* cisplatin + metoclopramide group, *GL* cisplatin + low-dose gingerol group, *GM* cisplatin + middle-dose gingerol group, *GH* cisplatin + high-dose gingerol group. ^\*^*P* \< 0.05 vs. Group C, ^‡^*P* \< 0.05 vs. Group CG, ^†^*P* \< 0.05 vs. Group V, ^§^*P* \< 0.05 vs. Group M, ^\|\|^*P* \< 0.05 vs. Group GL, ^¶^*P* \< 0.05 vs. Group GM. *TH* tyrosine hydroxylase
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